
We just hosted the largest AI x Bio hackathon this summer Now we are hosting episode 2. January 9-10 It's invite-only like last time, we only accept top biologist and best builders DM me for an early registration link

Diving into the deep end again (AI+Health)

We just hosted the largest AI x Bio hackathon this summer Now we are hosting episode 2. January 9-10 It's invite-only like last time, we only accept top biologist and best builders DM me for an early registration link

I joined @TheEconomist podcast to discuss how agentic AI is transforming the way we do science.
On this week’s “Babbage”, meet @james_y_zou, the man redefining science with AI agents. Listen now economist.com/podcasts/2026/…

Come build to kick off #JPM!
re:AGENT II is live, and applications are open! Drug development moves through distinct phases of work: deciding what to investigate and how, designing and interpreting a trial, and carrying evidence through approval and launch. This January, scientists and builders will spend a weekend building agents and the tools they need for those jobs. The three tracks follow that path: AI Scientist — discovery through IND AI Clinical Developer — the trial itself AI Pharma Operator — approval, launch, and beyond re:AGENT II is fully in person, January 9–10 in San Francisco, the weekend before JPM Healthcare Week. No AI experience is required; apply on your own or with a team. Applications close December 1. Application link in the comments. Thank you to our sponsors @Benchling @AnthropicAI @modal @FenwickWest @benchflow_ai @StrandAI @biohub @arcinstitute and futurebio #reAGENT #VirtualBiotech #AIforScience #DrugDevelopment #Biotech #Hackathon #JPM2027

This is incredible. Datasets appear to be highly relevant and accurate based on a couple quick tests. Wow!
Very excited to introduce Paperclip Datasets! Curate your own datasets from millions of papers in minutes. Just describe the dataset you want to build! As example, we release the largest dataset of 20k half-life human measurements curated from 2400+ drugs💊 🖇️ Try it: paperclip.gxl.ai/datasets 📝 Blog: gxl.ai/blog/introducing-pape… 📊 Half-life dataset: huggingface.co/datasets/gxl-…

Very excited to introduce Paperclip Datasets! Curate your own datasets from millions of papers in minutes. Just describe the dataset you want to build! As example, we release the largest dataset of 20k half-life human measurements curated from 2400+ drugs💊 🖇️ Try it: paperclip.gxl.ai/datasets 📝 Blog: gxl.ai/blog/introducing-pape… 📊 Half-life dataset: huggingface.co/datasets/gxl-…

We built Datasets based on a key insight: a tiny research team can have a good question or hunch and still face weeks of reading before they have the data to work on it. We want more of those questions to get a chance, faster. With Datasets, you describe the table you need and approve its columns. Agents then collect the values from papers, patents, clinical trials and regulatory documents. You can trust the values, because datasets shows you the exact passage behind it. We put together two case studies for launch: an open dataset of 19,952 human drug half-life measurements, and replications of 20 published meta-analyses. Agreement on effect direction and statistical significance averaged 90.3% across those papers. Here's the work behind both: gxl.ai/blog/introducing-pape… If there's a dataset you've wanted to build, give it a try: paperclip.gxl.ai/datasets
Paperclip Datasets is live! Describe the table you need, and agents collect the data from papers, patents, trials and regulatory documents. Each value links to its source passage so you can check it. Try it: paperclip.gxl.ai/datasets Read more here: gxl.ai/blog/introducing-pape…

if you're excited about ML infrastructure and engineering, Ortet is hiring *MIPs* -- Members of Intelligent Platform -- in NYC. Referrals are appreciated too! jobs.ashbyhq.com/ortet/974e8…
We’re releasing Ortet’s first health evaluation results: 34 open-weight models, 50 tasks, and 15 public benchmarks served and evaluated on Orion, our NVIDIA Blackwell GPU cluster. A few findings: - General rankings are not enough for health. - Open models are competitive on basic medical knowledge and are more willing research collaborators. - Both open and closed models struggle on the patient-prediction tasks we tested. - More reasoning usually helps, but the highest setting doesn’t always produce the best observed score. - Health rankings can be estimated with a small subset of questions. This is the first step towards our goal—to build continuously improving intelligence across the clinical, biological, and operational aspects of health. Read the blogpost: ortet.ai/blog/open-models-in… More on the findings below 🧵

What if, for any scientific claim, you can search 100M+ papers to find the strongest evidence for and against it ⚡️in 1 second? That’s now possible with Evidence API! 🚀 paperclip.gxl.ai/evidence-ap… For example, does drinking coffee reduce diabetes risk?

Try our new (very fast) Evidence API that returns supporting/refuting evidence for any scientific claim. In ~ 1s, you can: - Get citations to back up claims in your Intro and Related Works sections - Look up whether certain health claims are grounded in literature - Test autoresearch hypotheses at scale - etc. etc. etc.

re:AGENT was oversubscribed in August, so we're throwing another one at JPM in January. Save the date!
Save the date: re:AGENT is back! @GXL is hosting re:AGENT II, the hackathon for agentic science. The two-day build, from January 9th-10th, kicks off JPM week in San Francisco. Want to build or sponsor? Fill out the interest form in the comments Questions? Reach out to vanessa@gxl.ai

Exciting team and vision. Congratulations on the launch @OrtetAI !
i'm co-founding @OrtetAI to create continuously improving intelligence for every patient. we're hiring! please join the Ortet crews - @kchonyc @HenriDwyer @elmanmansimov @causalclaudia - more on ortet.ai

Nice @nytimes article discussing our AI scientist agents research! nytimes.com/2026/09/17/well/…
Super excited that #VirtualBiotech is published in @ScienceMagazine today! Tens of thousands of AI scientist agents work together across drug discovery + development, from target discovery to clinical trial design. Our blueprint for agentic R&D 🧵

🔥 Excited to share that #paper2agent is published in @Nature today! Papers have long been the primary format for communicating scientific knowledge, but they remain static. Putting that knowledge to work requires connecting findings to data, navigating supplementary materials, and adapting methods to new questions - effort repeated by each new reader. We introduce Paper2Agent, a multi-agent framework that automatically turns research papers into virtual authors. Paper2Agent turns a paper’s manuscript, code, data, and supplements into an MCP server that any AI agent can access, with automated testing and iterative refinement in an agentic loop. The paper then becomes a virtual author you can talk to: trace claims to evidence, analyze your own data, and collaborate with other papers’ virtual authors Agentifying a paper turns it from something people read into something people and AI agents can discover and build on - providing the context needed to interpret its findings and reuse its methods reliably. We tested how reliably these agents put papers to use. Across multiple benchmarks, agents created by Paper2Agent outperformed baselines such as Claude Code working directly with papers' PDFs and code repositories. Once papers become virtual authors, they can collaborate - much like human researchers do. In one case study, agents built from AlphaGenome and two large-scale genetic perturbation studies worked together to propose a new computational approach for integrating evidence across different perturbation datasets. By connecting predictions from one paper with experimental data from others, they helped pinpoint a likely causal gene for psoriasis. We hope Paper2Agent makes scientific knowledge easier to access, reuse, and build on - a first step toward a future where millions of paper agents proactively collaborate with human researchers and one another to advance discovery. 🤖Talk to the virtual author for Paper2Agent itself: paper2agent.ai 📎Paper: nature.com/articles/s41586-0… 💻Code: github.com/jmiao24/Paper2Age… VERY grateful to work with this incredible team: @james_y_zou, @jkpritch, Yaohui, and Joe!

Yes.
in the first chapter of healthcare AI, the battleground was access to longitudinal clinical data. in this next phase, it will be access to biological specimens: tissue, blood, synovial fluid, and other samples containing 1,000× more information, linked to clinical context and longitudinal outcomes. the winners will be those who can access, assay, and interpret these specimens at the lowest cost and highest resolution.

Fun thing from the @gxl_ai team today, check out Paper Scorecard: paperclip.gxl.ai/scorecard/
Your paper is cited 200 times. Maybe 8 of them actually read it. Paper Scorecard finds those 8 and surfaces the real critiques buried in literature. Fascinating to see what papers really say about each other! paperclip.gxl.ai/scorecard/

Your paper is cited 200 times. Maybe 8 of them actually read it. Paper Scorecard finds those 8 and surfaces the real critiques buried in literature. Fascinating to see what papers really say about each other! paperclip.gxl.ai/scorecard/